Presenting the results at the European Association for the Study of Diabetes (EASD) 2016 Annual Meeting, Ahmed Albehairy, MD, from Mansoura University, Egypt, said: “In patients who received the mesenchymal stem cells, ulcer reduction was found to be significantly higher compared with patients on conventional treatment after both 6 weeks and 12 weeks of follow-up. This is despite the fact that initial ulcer size was larger in the stem-cell–treated group.”

[pdf-embedder url=”https://www.nsorm.com/wp-content/uploads/2018/07/Nearly-50-Reduction-in-Diabetic-Foot-Ulcers-With-Stem-Cells.pdf” title=”Nearly 50% Reduction in Diabetic Foot Ulcers With Stem Cells”]